Weihong Tan, PhD
Dr. Weihong Tan earned his Ph.D. in physical chemistry at the University of Michigan in 1993. He is the President of the Institute of Basic Medicine and Cancer, Chinese Academy of Sciences; Director of the Institute of Molecular Medicine, Shanghai Jiao Tong University, and Director of the State Key Laboratory of Chemo/Biosensing and Chemometrics and Distinguished Professor of Chemistry and Biology at Hunan University. He started his academic career in 1995 at the University of Florida after being a Distinguished Postdoctoral Fellow at Ames Lab, US-DOE. He was promoted to associate professor in 2001 and full professor in 2003. He started his major research activity at Hunan University in 2010.
Dr. Tan’s research is in the general area of Bioanalytical Chemistry, Molecular Medicine, and Chemical Biology. He specializes in aptamer research and DNA nanotechnology, as well as cancer theranostics. He has published over 690 peer-reviewed scientific papers. According to Thomson Reuters, he is among the small, prestigious group of Highly Cited Researchers for the period between 2014-2019. the total citations of his publications exceed 62,000 with an H index of 148. He is currently an Associate Editor for JACS (Journal of American Chemical Society). He has received over thirty awards and honors, including the Beckman Young Investigator Award in 1997, the Pittcon Achievement Award in 2004, the AAAS Fellow in 2005, the ACS Florida Award in 2012, Academician of the Chinese Academy of Sciences in 2015, Academician of the World Academy of Sciences in Developing COuntires in 2016, member of the European Academy of Science in 2019, and the Award in Spectrochemical Analysis from the American Chemical Society in 2018, Prize for Scientific and Technological Progress, Ho Leung Ho Lee Foundation in 2018, the Ralph Adams Award for Bioanalytical Chemistry in 2019, and the Pittsburgh Analytical Chemistry Award in 2019.
For a more thorough list of Dr. Tan’s publications, please click the link below:
I am a molecular scientist and perceive the world from a molecular point of view. I consider the human body as a molecular machine and believe that every biological process can be explained by its molecular basis.
Dr. Tan Leads Research Groups at Three Elite Institutes
Developing first-in-class drugs and employing pattern recognition-based molecular diagnostics are the two major areas of R&D at his labs.
Each institute has its own set of strengths for pushing forward science.
Hunan University (Changsha)
Shanghai Jiao Tong University (Shanghai)
Innovation requires healthy collaboration.
Feel free to email me at firstname.lastname@example.org to connect.